Explore more publications!
STEM Times Cayman Islands
Got News to Share?

STEM Times Cayman Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times Cayman Islands.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 6, 2026

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
Apr. 6, 2026

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026

Indeterminate GlobeNewswire
Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention
Apr. 6, 2026

Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention

Indeterminate GlobeNewswire
nCino Analyst Digital Partner Cuts Commercial Relationship Review Time by Up to 70%, Enabling Financial Institutions to Build an AI-Augmented Credit Workforce
Apr. 6, 2026

nCino Analyst Digital Partner Cuts Commercial Relationship Review Time by Up to 70%, Enabling Financial Institutions to Build an AI-Augmented Credit Workforce

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories Shatters Production Record, Delivering Over 1.3 Metric Tons of Spider Silk Cocoons in a Single Month, A 5X Increase Over Previous High
Apr. 6, 2026

Kraig Biocraft Laboratories Shatters Production Record, Delivering Over 1.3 Metric Tons of Spider Silk Cocoons in a Single Month, A 5X Increase Over Previous High

Indeterminate GlobeNewswire
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr. 6, 2026

Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Stipple Bio Emerges From Stealth with Oversubscribed $100 Million Series A Financing to Advance STP-100 into Early Clinical Studies and Advance a Precision Oncology Pipeline that Leverages its Pointillist Platform
Apr. 6, 2026

Stipple Bio Emerges From Stealth with Oversubscribed $100 Million Series A Financing to Advance STP-100 into Early Clinical Studies and Advance a Precision Oncology Pipeline that Leverages its Pointillist Platform

Indeterminate GlobeNewswire
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
Apr. 6, 2026

BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer

Indeterminate GlobeNewswire
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Apr. 6, 2026

Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
Apr. 6, 2026

Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET
Apr. 6, 2026

Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET

Indeterminate GlobeNewswire
Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital
Apr. 6, 2026

Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital

Indeterminate GlobeNewswire
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application
Apr. 6, 2026

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application

Indeterminate GlobeNewswire
Arkansas Otolaryngology Center Selects CareCloud to Power Next-Level Practice Management and Revenue Optimization with AI-Enabled Solutions
Apr. 6, 2026

Arkansas Otolaryngology Center Selects CareCloud to Power Next-Level Practice Management and Revenue Optimization with AI-Enabled Solutions

Indeterminate GlobeNewswire
Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference
Apr. 6, 2026

Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
Red Cat Expands Blue Ops Manufacturing Capabilities Though Strategic Partnership with HADDY
Apr. 6, 2026

Red Cat Expands Blue Ops Manufacturing Capabilities Though Strategic Partnership with HADDY

Indeterminate GlobeNewswire
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform
Apr. 6, 2026

Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform

Indeterminate GlobeNewswire
Cygnet.One strengthens global e-Invoicing capabilities with expanded accreditations and enhanced support for Malaysia’s LHDN & MDEC framework
Apr. 6, 2026

Cygnet.One strengthens global e-Invoicing capabilities with expanded accreditations and enhanced support for Malaysia’s LHDN & MDEC framework

Indeterminate GlobeNewswire
Bitcoin Poker No Deposit Bonus 2026: BC Poker Offers $5 Free With No Cashout Cap, BC Shield Anti-Cheat Protection, and Instant Crypto Withdrawals
Apr. 6, 2026

Bitcoin Poker No Deposit Bonus 2026: BC Poker Offers $5 Free With No Cashout Cap, BC Shield Anti-Cheat Protection, and Instant Crypto Withdrawals

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions